Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Blood
|
May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
David T Teachey, Susan R Rheingold, Shannon L Maude, et al.
Blood
|
December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Waleed Haso, Daniel W Lee, Nirali N Shah, et al.
Critical Care Medicine
|
September 16, 2016
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
Julie C Fitzgerald, Scott L Weiss, Shannon L Maude, et al.
Blood
|
December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy
Allison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 1, 2020
Human Adenovirus 7-Associated Hemophagocytic Lymphohistiocytosis-like Illness: Clinical and Virological Characteristics in a Cluster of Five Pediatric Cases
William R Otto, Edward M Behrens, David T Teachey, et al.
Science Advances
|
June 8, 2022
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL
Zhiliang Bai, Steven Woodhouse, Ziran Zhao, et al.
Pediatric Blood & Cancer
|
March 23, 2021
Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective
Michael P Triebwasser, David M Barrett, Hamid Bassiri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 26, 2019
Partially CD3<sup>+</sup>-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy
Alix E Seif, Yimei Li, Dimitri S Monos, et al.
Blood
|
June 5, 2015
Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein
Haiying Qin, Monica Cho, Waleed Haso, et al.
Cancer Immunology Research
|
July 22, 2018
Reducing <i>Ex Vivo</i> Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi, Selene Nunez-Cruz, Roddy S O'Connor, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Blood
|
May 17, 2013
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
David T Teachey, Susan R Rheingold, Shannon L Maude, et al.
Blood
|
December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Waleed Haso, Daniel W Lee, Nirali N Shah, et al.
Critical Care Medicine
|
September 16, 2016
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
Julie C Fitzgerald, Scott L Weiss, Shannon L Maude, et al.
Blood
|
December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy
Allison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 1, 2020
Human Adenovirus 7-Associated Hemophagocytic Lymphohistiocytosis-like Illness: Clinical and Virological Characteristics in a Cluster of Five Pediatric Cases
William R Otto, Edward M Behrens, David T Teachey, et al.
Science Advances
|
June 8, 2022
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL
Zhiliang Bai, Steven Woodhouse, Ziran Zhao, et al.
Pediatric Blood & Cancer
|
March 23, 2021
Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective
Michael P Triebwasser, David M Barrett, Hamid Bassiri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 26, 2019
Partially CD3<sup>+</sup>-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy
Alix E Seif, Yimei Li, Dimitri S Monos, et al.
Blood
|
June 5, 2015
Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein
Haiying Qin, Monica Cho, Waleed Haso, et al.
Cancer Immunology Research
|
July 22, 2018
Reducing <i>Ex Vivo</i> Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi, Selene Nunez-Cruz, Roddy S O'Connor, et al.
Page
of 8